Pursuant to Regulation 30 of SEBI (LODR) regulation 2015 for the board meeting held on 23rd September 2026.

Date: September 23rd 2026 The Manager, Corporate Services Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, Maharashtra - 400 001 Scrip Code: 543546 Scrip Symbol: HEALTHYLIFE Subject: Outcome of the Board Meeting held today i.e. Wednesday, September 23, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. Wednesday, September 23, 2026, has, inter-alia, considered and approved raising of funds through the issuance of partly paid-up equity shares of face value ₹10 each by way of rights issue for an amount not exceeding Rs. 5,000 Lakhs, to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently), subject to receipt of statutory / regulatory approvals in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (the “SEBI ICDR Regulations”) and other applicable regulations and subject to necessary approvals as may be required. For the purposes of giving effect to the rights issue, the specific and detailed terms in relation to the rights issue, including but not limited to the determination of the issue price, rights entitlement ratio, record date, timing of the rights issue, terms of payment and other related matters will be determined by the Board and / or the Rights Issue Committee of the Board, in accordance with applicable laws, subject to receipt of necessary approvals, as may be required. In this regard, Board has formed a Rights Issue committee, consisting the following members of the Board as its members: 1. Divya Mojjada – Chairperson 2. Mohammed Sadiq – Member 3. Apra Sharma – Member Requisite details for the aforesaid in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (“SEBI Master Circular”), is enclosed as Annexure – A. The meeting of the Board commenced at 12:00 P.M. (IST) and concluded at 1:45 P.M (IST). This is for your kind information. You are requested to kindly take the above on your record. Thanking you, For Healthy Life Agritec Limited Divya Mojjada Managing Director DIN: 07759911 Encl: as above ANNEXURE – A Disclosures as required under Regulation 30 read with Schedule III of the SEBI Listing Regulations Sl. Particulars Details 1 Type of securities proposed to be issued Equity shares having face value of ₹10 each (partly paid-up) 2 Type of issuance Rights Issue 3 Total number of securities proposed to be issued Number of equity shares proposed to be issued or the total amount for which the securities will shall be determined after receiving in-principle be issued (approximately) approval from the Stock Exchange. Total amount for which the equity shares will be issued is up to ₹5,000 Lakhs (Rupees Five Thousand Lakhs Only). For Healthy Life Agritec Limited Divya Mojjada Managing Director DIN: 07759911